We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$20.1B
AUM Growth
+$951M
Cap. Flow
-$224M
Cap. Flow %
-1.12%
Top 10 Hldgs %
32.44%
Holding
721
New
63
Increased
299
Reduced
261
Closed
36

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$55.1M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$46.1M
3
BABA icon
Alibaba
BABA
+$45M
4
NEE icon
NextEra Energy
NEE
+$40.9M
5
AMZN icon
Amazon
AMZN
+$38.3M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$50.3M
2
META icon
Meta Platforms (Facebook)
META
+$44.2M
3
PG icon
Procter & Gamble
PG
+$34.1M
4
ZTS icon
Zoetis
ZTS
+$33.6M
5
CAH icon
Cardinal Health
CAH
+$32.2M

Sector Composition

Rank Sector Weight
1 Technology 34.01%
2 Healthcare 26.73%
3 Financials 11.13%
4 Consumer Discretionary 7.93%
5 Communication Services 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
76
Biogen
BIIB
$29.9B
$58.2M 0.29%
330,472
+171,651
+108% +$28M
TRMB icon
77
Trimble
TRMB
$13.5B
$58.1M 0.29%
741,754
-145,223
-16% -$11.6M
SYK icon
78
Stryker
SYK
$132B
$57.8M 0.29%
164,452
-12,982
-7% -$4.73M
BNTX icon
79
BioNTech
BNTX
$23.3B
$57.6M 0.29%
604,916
+15,464
+3% +$1.56M
DIS icon
80
Walt Disney
DIS
$172B
$56M 0.28%
491,819
-138,921
-22% -$15.3M
VEEV icon
81
Veeva Systems
VEEV
$32.8B
$55.7M 0.28%
249,350
-9,434
-4% -$2.5M
NFLX icon
82
Netflix
NFLX
$304B
$55.5M 0.28%
591,617
-139,873
-19% -$15.1M
QCOM icon
83
Qualcomm
QCOM
$172B
$55.4M 0.28%
324,159
-16,749
-5% -$2.87M
PGR icon
84
Progressive
PGR
$129B
$54.9M 0.27%
241,047
-107,757
-31% -$24.3M
GEV icon
85
GE Vernova
GEV
$249B
$54.7M 0.27%
83,644
-27,934
-25% -$17M
ROIV icon
86
Roivant Sciences
ROIV
$24.2B
$54M 0.27%
2,490,426
+332,431
+15% +$6.56M
IONS icon
87
Ionis Pharmaceuticals
IONS
$8.95B
$53.6M 0.27%
677,629
+66,392
+11% +$5M
EXC icon
88
Exelon
EXC
$48.7B
$52.4M 0.26%
1,202,609
+4,566
+0.4% +$208K
AWK icon
89
American Water Works
AWK
$27B
$51.5M 0.26%
394,710
+8,891
+2% +$1.19M
TERN
90
DELISTED
Terns Pharmaceuticals
TERN
$51M 0.25%
1,262,303
-1,105,932
-47% -$25.6M
KO icon
91
Coca-Cola
KO
$378B
$49.8M 0.25%
711,745
+48,349
+7% +$3.37M
PFE icon
92
Pfizer
PFE
$144B
$49.1M 0.25%
1,972,749
-60,553
-3% -$1.53M
PTC icon
93
PTC
PTC
$14.9B
$49M 0.24%
281,075
-21,191
-7% -$3.94M
BMY icon
94
Bristol-Myers Squibb
BMY
$130B
$48.9M 0.24%
906,714
+9,451
+1% +$455K
CELC icon
95
Celcuity
CELC
$3.99B
$47.5M 0.24%
476,370
+85,446
+22% +$7.02M
HCA icon
96
HCA Healthcare
HCA
$91.3B
$47.2M 0.24%
101,001
+1,899
+2% +$882K
COGT icon
97
Cogent Biosciences
COGT
$6.8B
$46.1M 0.23%
1,296,475
+342,266
+36% +$9.62M
INCY icon
98
Incyte
INCY
$25.8B
$45.4M 0.23%
460,070
-293,262
-39% -$28.4M
MIRM icon
99
Mirum Pharmaceuticals
MIRM
$6.79B
$45M 0.22%
569,590
+166,564
+41% +$12M
CRDO icon
100
Credo Technology Group
CRDO
$36.2B
$43.5M 0.22%
301,987
-116,784
-28% -$18M

Similar funds

Candriam SCA's Q4 2025 Portfolio in Review

As of Q4 2025, Candriam SCA held 721 positions worth $20.1B, up 5% from $19.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q4 2025 filing shows 63 new, 299 increased, 261 reduced and 36 closed positions. Its largest new stake was Alibaba: 276,080 shares worth $40.5M. The largest sale was Equinix, an estimated $50.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q4 2025 buy was Alibaba: 276,080 shares worth $40.5M.
  • Candriam SCA added most to AbbVie in Q4 2025, an estimated $55.1M increase.
  • Candriam SCA's biggest Q4 2025 reduction was Equinix, cutting an estimated $50.3M.
  • Candriam SCA fully exited Universal Display in Q4 2025, selling an estimated $27.1M.
  • Candriam SCA's ten largest holdings make up 32% of its $20.1B portfolio in Q4 2025.
  • Candriam SCA opened 63 new positions and closed 36 in Q4 2025.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $20.1B.

Based on Candriam SCA's 13F filing for Q4 2025, filed 13 Feb 2026.